These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1888640)

  • 21. Evolution of atenolol kinetics when hypothyroidism is corrected.
    Levesque H; Richard MO; Fresel J; Gancel A; Moore N; Courtois H
    Eur J Clin Pharmacol; 1990; 38(2):185-8. PubMed ID: 2338117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of dietary protein content on nalidixic acid disposition in chickens.
    Abd el-Aziz MI; Afify NA; Kamel FM
    Dtsch Tierarztl Wochenschr; 1995 May; 102(5):195-8. PubMed ID: 8593772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans.
    Barre J; Houin G; Tillement JP
    J Pharm Sci; 1984 Oct; 73(10):1379-82. PubMed ID: 6594505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic model for nalidixic acid in man. 3. Effect of repeated oral dosage.
    McChesney EW; Portmann GA; Koss RF
    J Pharm Sci; 1967 May; 56(5):594-9. PubMed ID: 6032771
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of itraconazole on the pharmacokinetics of atenolol.
    Lilja JJ; Backman JT; Neuvonen PJ
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):395-8. PubMed ID: 16364056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of pharmacokinetic and pharmacodynamic relationship for oral sustained-release atenolol pellets in rats.
    Jia J; Dong C; Zhang W; Cui Y; Liu J
    J Pharm Biomed Anal; 2011 May; 55(2):342-8. PubMed ID: 21353427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of E. coli infection on the disposition kinetic of nalidixic acid in broiler chickens.
    Atef M; Youssef SA; Amer AM; el-Banna HA
    Dtsch Tierarztl Wochenschr; 1992 Apr; 99(4):140-3. PubMed ID: 1606894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on the pharmacokinetics of nalidixic acid in children of different ages].
    Rohwedder HJ; Simon C; Kübler W; Hohenauer M
    Z Kinderheilkd; 1970; 109(2):124-34. PubMed ID: 5494205
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics and pharmacodynamics of atenolol in children.
    Buck ML; Wiest D; Gillette PC; Trippel D; Krull J; O'Neal W
    Clin Pharmacol Ther; 1989 Dec; 46(6):629-33. PubMed ID: 2598566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioequivalence study of generic atenolol tablets in healthy Thai volunteers.
    Rojanasthien N; Manorot M; Kumsorn B
    J Med Assoc Thai; 1999 Sep; 82(9):907-14. PubMed ID: 10561948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum.
    Hebert MF; Carr DB; Anderson GD; Blough D; Green GE; Brateng DA; Kantor E; Benedetti TJ; Easterling TR
    J Clin Pharmacol; 2005 Jan; 45(1):25-33. PubMed ID: 15601802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic behaviour and tissue distribution of nalidixic acid in chickens.
    Atef M; Youssef SA; Amer AM; el-Bana HA; Hessen RM
    Dtsch Tierarztl Wochenschr; 1991 Aug; 98(8):303-6. PubMed ID: 1935680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect on heart rate of combining single-dose fingolimod with steady-state atenolol or diltiazem in healthy subjects.
    Kovarik JM; Lu M; Riviere GJ; Barbet I; Maton S; Goldwater DR; Schmouder RL
    Eur J Clin Pharmacol; 2008 May; 64(5):457-63. PubMed ID: 18196225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of gastrointestinal transit on drug absorption in healthy volunteers.
    Riley SA; Sutcliffe F; Kim M; Kapas M; Rowland M; Turnberg LA
    Br J Clin Pharmacol; 1992 Jul; 34(1):32-9. PubMed ID: 1633065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral bioavailability of atenolol.
    Vergin H; Nitsche V
    J Int Med Res; 1989; 17(5):417-25. PubMed ID: 2806714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereoselective HPLC bioanalysis of atenolol enantiomers in plasma: application to a comparative human pharmacokinetic study.
    Egginger G; Lindner W; Kahr S; Stoschitzky K
    Chirality; 1993; 5(7):505-12. PubMed ID: 8240927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative pharmacokinetics and bioequivalence of two 50 mg atenolol tablet formulations in healthy Korean male volunteers.
    Chang MJ; Shin WG
    Arzneimittelforschung; 2012 Sep; 62(9):410-3. PubMed ID: 22791245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of nalidixic acid associated with sodium citrate.
    Ferry N; Cuisinaud G; Sassard J; Pozet N; Zech PY
    Biopharm Drug Dispos; 1984; 5(3):211-8. PubMed ID: 6487750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioequivalence of a new atenolol formulation.
    Rostock G; Vogel I; Stulich M; Günzel R
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):482-3. PubMed ID: 1490794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The pharmacokinetics of nalidixic acid administered parenterally. Towards rational use in severe infections (author's transl)].
    Tillement JP; Houin G; Lhoste F; d'Athis P; Lartigue C; Rapin M
    Nouv Presse Med; 1979 May; 8(23):1911-4. PubMed ID: 461153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.